Reports of Patent, Design, and Trade Mark Cases, Issues 1-5; Issues 8-13Published at the Patent Office Sales Branch, 2003 - Industrial property |
From inside the book
Results 1-3 of 79
Page 69
... clear enough and complete enough for the invention to be performed . That is equivalent to s.72 ( 1 ) ( c ) . Section 14 ( 5 ) is as follows : " ( 5 ) The claim or claims shall- ( a ) define the matter for which the applicant seeks ...
... clear enough and complete enough for the invention to be performed . That is equivalent to s.72 ( 1 ) ( c ) . Section 14 ( 5 ) is as follows : " ( 5 ) The claim or claims shall- ( a ) define the matter for which the applicant seeks ...
Page 118
... clear description of , or clear instructions to do or make , something that would infringe the patentee's claim if carried out after the grant of the patentee's patent , the patentee's claim will have been shown to lack the necessary ...
... clear description of , or clear instructions to do or make , something that would infringe the patentee's claim if carried out after the grant of the patentee's patent , the patentee's claim will have been shown to lack the necessary ...
Page 125
... clear I can see no reason why the Synthon application should not support a claim to priority for any product of which it is an enabling disclosure . I accept that you can find statements in the law in the decisions of the Technical ...
... clear I can see no reason why the Synthon application should not support a claim to priority for any product of which it is an enabling disclosure . I accept that you can find statements in the law in the decisions of the Technical ...
Other editions - View all
Common terms and phrases
ALBERTA FERRETTI amendment Amgen amino acid Appointed Person Arsenal FC Arsenal Football Club burner cell claim 19 claimant colour common general knowledge contact lens CooperVision Court of Appeal cross-examination Davies decision defendants Directive distinctive character DNA sequence dots earlier trade mark effect erythropoietin European Patent evidence filed gene hearing officer High Court Inc v Transkaryotic infringement Integer inventive step iris section issue judge judgment Kirin-Amgen Inc lenses likelihood of confusion Ltd's Trade Mark Marks Act 1994 Meneghetti non-use opponent paragraph numbers paras Patent Office Philips Electronics NV Plc v Reed prior art priority date protein question Quickfit reason Reed Business Information referred registered trade mark registrar relation relevant Remington Consumer Products revocation shape Silverleaf specification submissions Sweet & Maxwell Synthon third party TORRES TRADE MARK 2003 Trade Mark Application trade mark proprietor Trade Marks Act Transkaryotic Therapies Inc uEPO United Kingdom word